These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 25124187)
1. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality. Ye QF; Zhao J; Wan QQ; Qiao BB; Zhou JD Transpl Infect Dis; 2014 Oct; 16(5):767-74. PubMed ID: 25124187 [TBL] [Abstract][Full Text] [Related]
2. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; Roca J; Cruzado JM; Carratalà J Transplantation; 2013 Nov; 96(9):843-9. PubMed ID: 23883973 [TBL] [Abstract][Full Text] [Related]
3. The risk factors for mortality and septic shock in liver transplant recipients with ESKAPE bacteremia. Ouyang W; Li X; Wan Q; Ye Q Hepatogastroenterology; 2015; 62(138):346-9. PubMed ID: 25916061 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for mortality in liver transplant recipients with ESKAPE infection. Song SH; Li XX; Wan QQ; Ye QF Transplant Proc; 2014 Dec; 46(10):3560-3. PubMed ID: 25498089 [TBL] [Abstract][Full Text] [Related]
5. Mortality Predictors in Acute Respiratory Distress Syndrome Renal Transplant Recipients With ESKAPE/rESKAPE Pneumonia. Chu L; Ye QF; Wan QQ; Zhou JD Transplant Proc; 2015 Oct; 47(8):2450-5. PubMed ID: 26518949 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections. Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600 [TBL] [Abstract][Full Text] [Related]
7. Changes in the incidence and antimicrobial susceptibility of healthcare-associated infections in a New York hospital system, 2006-2012. Cohen B; Liu J; Larson E J Prev Med Hyg; 2017 Dec; 58(4):E294-E301. PubMed ID: 29707660 [TBL] [Abstract][Full Text] [Related]
8. Predictors of shock and mortality in solid organ transplant recipients with bacteremia caused by non-lactose-fermenting gram-negative bacilli. Wan Q; Luo A; Ye Q; Liu S; Zhou J Infect Dis (Lond); 2016; 48(1):32-9. PubMed ID: 26329287 [TBL] [Abstract][Full Text] [Related]
9. Nosocomial bloodstream infections in a nationwide study: comparison between solid organ transplant patients and the general population. Camargo LF; Marra AR; Pignatari AC; Sukiennik T; Behar PP; Medeiros EA; Ribeiro J; Girão E; Correa L; Guerra C; Brites C; Pereira CA; Carneiro I; Reis M; Souza MA; Barata CU; Edmond MB; Transpl Infect Dis; 2015 Apr; 17(2):308-13. PubMed ID: 25726707 [TBL] [Abstract][Full Text] [Related]
10. Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis. Leão AC; Menezes PR; Oliveira MS; Levin AS BMC Infect Dis; 2016 Aug; 16():386. PubMed ID: 27506948 [TBL] [Abstract][Full Text] [Related]
11. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program. Diekema DJ; Hsueh PR; Mendes RE; Pfaller MA; Rolston KV; Sader HS; Jones RN Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010862 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients. Bodro M; Gudiol C; Garcia-Vidal C; Tubau F; Contra A; Boix L; Domingo-Domenech E; Calvo M; Carratalà J Support Care Cancer; 2014 Mar; 22(3):603-10. PubMed ID: 24170166 [TBL] [Abstract][Full Text] [Related]
13. Update on the main MDR pathogens: prevalence and treatment options. Esposito S; De Simone G Infez Med; 2017 Dec; 25(4):301-310. PubMed ID: 29286008 [TBL] [Abstract][Full Text] [Related]
14. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED. Kang CI; Chung DR; Peck KR; Song JH; Am J Emerg Med; 2012 Sep; 30(7):1169-75. PubMed ID: 22030178 [TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus bacteremia in solid organ transplant recipients: evidence for improved survival when compared with nontransplant patients. Malinis MF; Mawhorter SD; Jain A; Shrestha NK; Avery RK; van Duin D Transplantation; 2012 May; 93(10):1045-50. PubMed ID: 22357175 [TBL] [Abstract][Full Text] [Related]
16. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. Robenshtok E; Paul M; Leibovici L; Fraser A; Pitlik S; Ostfeld I; Samra Z; Perez S; Lev B; Weinberger M J Hosp Infect; 2006 Nov; 64(3):282-7. PubMed ID: 16930770 [TBL] [Abstract][Full Text] [Related]
17. Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012. Fransén J; Huss FR; Nilsson LE; Rydell U; Sjöberg F; Hanberger H Burns; 2016 Sep; 42(6):1295-303. PubMed ID: 27241732 [TBL] [Abstract][Full Text] [Related]
18. Infection in burn patients in a referral center in Colombia. Ramirez-Blanco CE; Ramirez-Rivero CE; Diaz-Martinez LA; Sosa-Avila LM Burns; 2017 May; 43(3):642-653. PubMed ID: 28185802 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii. Fu Q; Ye H; Liu S Am J Infect Control; 2015 Aug; 43(8):857-60. PubMed ID: 25960385 [TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients. Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]